Fidelity SPDR Advertisement
Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

There is a "buyout rumor" circulating right now,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Superfly15 Member Profile
 
Followed By 39
Posts 2,720
Boards Moderated 0
Alias Born 03/23/10
160x600 placeholder
Notification That Annual Report Will Be Submitted Late (nt 10-k) "Edgar (US Regulatory)" - 12/12/2014 4:33:01 PM
CEL-SCI Expands Its Pivotal Phase III Immunotherapy Head and Neck Cancer Trial With Addition of 7 More Clinical Sites "Business Wire" - 12/8/2014 8:45:00 AM
CEL-SCI Quarterly Patient Enrollment in Its Head & Neck Cancer Phase III Trial Increases Eight Fold over Same Prior Year Period "Business Wire" - 12/2/2014 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/7/2014 2:58:41 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 11/5/2014 9:27:10 AM
CEL-SCI Enrolls 22 Patients During October in Its Phase III Immunotherapy Head and Neck Cancer Trial "Business Wire" - 11/3/2014 8:30:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/28/2014 4:49:23 PM
CEL-SCI Corporation Announces Closing of Public Offering for Gross Proceeds of $6 Million "Business Wire" - 10/24/2014 10:09:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/23/2014 3:48:59 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/22/2014 6:01:41 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 10/22/2014 6:01:41 AM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) "Edgar (US Regulatory)" - 10/22/2014 6:01:40 AM
CEL-SCI Corporation to Raise $1 Million in Registered Direct Offering "Business Wire" - 10/21/2014 9:42:00 AM
CEL-SCI Corporation Prices $6 Million Public Offering of Common Stock and Warrants "Business Wire" - 10/21/2014 9:15:00 AM
CEL-SCI Corporation Announces Proposed Public Offering of Common Stock and Warrants "Business Wire" - 10/20/2014 4:30:00 PM
Prospectus Filed Pursuant to Rule 424(b)(3) (424b3) "Edgar (US Regulatory)" - 10/20/2014 4:27:28 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/14/2014 9:49:50 AM
CEL-SCI Enrolls 16 Patients in September in Its Phase III Immunotherapy Head and Neck Cancer Trial "Business Wire" - 10/3/2014 9:15:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 3:53:38 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 3:50:33 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 3:46:26 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 10/1/2014 3:43:02 PM
CEL-SCI & U.S. Navy Administer Multikine to First Volunteer Patient in Phase I Clinical Trial for Treatment of Anal Warts in ... "Business Wire" - 9/29/2014 8:00:00 AM
University of Minnesota Masonic Cancer Center Joins CEL-SCI’s Phase III Head & Neck Cancer Trial "Business Wire" - 9/10/2014 8:45:00 AM
CEL-SCI Enrolls 20 Patients in August in Its Phase III Immunotherapy Head and Neck Cancer Trial "Business Wire" - 9/3/2014 8:00:00 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist